Abstract
Ribonuclease inhibitor (RI), a 50 kDa protein, has been found both in mammalian and nonmammalian tissues. We have isolated RI from goat liver and partial characterization has been accomplished. For the isolation of RI, DEAE cellulose column chromatography followed by affinity chromatography using CNBr activated Sepharose 4B was performed. The inhibition of ribonucleolytic activity of Ribonuclease A has been checked by an agarose gel based assay. The antiangiogenic property of the protein was tested by the chorioallantoic membrane (CAM) assay. Results indicate inhibition of angiogenesis.
Keywords: Ribonuclease inhibitor, agarose gel based assay, angiogenesis, CAM assay
Protein & Peptide Letters
Title: Isolation and Partial Characterization of Ribonuclease Inhibitor from Goat Liver
Volume: 13 Issue: 8
Author(s): Juin Chatterjee, Tushar Kanti Maiti and Swagata Dasgupta
Affiliation:
Keywords: Ribonuclease inhibitor, agarose gel based assay, angiogenesis, CAM assay
Abstract: Ribonuclease inhibitor (RI), a 50 kDa protein, has been found both in mammalian and nonmammalian tissues. We have isolated RI from goat liver and partial characterization has been accomplished. For the isolation of RI, DEAE cellulose column chromatography followed by affinity chromatography using CNBr activated Sepharose 4B was performed. The inhibition of ribonucleolytic activity of Ribonuclease A has been checked by an agarose gel based assay. The antiangiogenic property of the protein was tested by the chorioallantoic membrane (CAM) assay. Results indicate inhibition of angiogenesis.
Export Options
About this article
Cite this article as:
Chatterjee Juin, Kanti Maiti Tushar and Dasgupta Swagata, Isolation and Partial Characterization of Ribonuclease Inhibitor from Goat Liver, Protein & Peptide Letters 2006; 13 (8) . https://dx.doi.org/10.2174/092986606777841307
DOI https://dx.doi.org/10.2174/092986606777841307 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nano-Based Anti-Tubercular Drug Delivery and Therapeutic Interventions in Tuberculosis
Current Drug Targets Thermodynamics and information Physics Offer New Opportunities in Cancer Therapy
Current Cancer Therapy Reviews Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Cyclic Voltammetry-An Electrochemical Approach to Study Metal-based Potential Antitumor Drug-DNA Interaction
Current Analytical Chemistry Stimuli-responsive Drug Delivery Nanosystems: From Bench to Clinic
Current Nanomedicine Fish Hydrolysates: A Regulatory Perspective of Bioactive Peptides
Protein & Peptide Letters Serial Analysis of Gene Expression in Eukaryotic Pathogens
Infectious Disorders - Drug Targets Characterization of Phosphorylated Proteins Using Mass Spectrometry
Current Protein & Peptide Science Synthesis and Characterization of Poly([1,2,4]triazolyl- and [1,2,4]triazolo[3,4- b][1,3,4]thiadiazinylsulfanylmethyl)arenes: Novel Multi-Armed Molecules.
Current Organic Synthesis Increased Production of Recombinant O-Phospho-L-Serine Sulfhydrylase from the Hyperthermophilic Archaeon Aeropyrum pernix K1 Using Escherichia coli
Current Biotechnology Antioxidant Properties and Polyphenol Screening of the Leaves of Native Hungarian Oak (<i>Quercus</i>) Species
Current Bioactive Compounds Objective Biomarkers or Symptom Scores for the Classification of Fibromyalgia Syndrome?
Current Rheumatology Reviews Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease
Current Pharmacogenomics Chemoprevention of Skin Cancer: Effect of Lawsonia inermis L. (Henna) Leaf Powder and its Pigment Artifact, Lawsone in the Epstein- Barr Virus Early Antigen Activation Assay and in Two-Stage Mouse Skin Carcinogenesis Models
Anti-Cancer Agents in Medicinal Chemistry In Silico Predictions of ADME-Tox Properties: Drug Absorption
Combinatorial Chemistry & High Throughput Screening Curcumin - Properties, Applications and Modification of Structure
Mini-Reviews in Organic Chemistry Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets Electrochemical DNA Sensors: From Nanoconstruction to Biosensing
Current Organic Chemistry New Derivatives of GnRH as Potential Anticancer Therapeutic Agents
Current Medicinal Chemistry Developing of A Novel Clinical Kit for Assaying of Alpha-fetoprotein Based on Luminescent and Magnetic Nanoparticles
Current Nanoscience